Nitrone derivatives of trolox as neuroprotective agents

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 12, 2005, Pages 3012-3015

  Balogh, György T ^a   Vukics, Krisztina ^a   Könczöl, Árpád ^b   Kis Varga, Ágnes ^a   Gere, Anikó ^a   Fischer, János ^a  

^a GEDEON RICHTER LTD   (Hungary)

^b BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

Author keywords

Free radical scavenging; Lipid peroxidation; Neuroprotection; Nitrone; Permanent middle cerebral artery occlusion; Trolox

Indexed keywords

DISUFENTON SODIUM; FERROUS ION; FREE RADICAL; NITRONE DERIVATIVE; SCAVENGER; TROLOX C;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; IN VITRO STUDY; LIPID PEROXIDATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; RAT; REFERENCE VALUE;

ANIMALS; ANTIOXIDANTS; ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CHROMANS; FREE RADICAL SCAVENGERS; HYDROXYL RADICAL; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPID PEROXIDATION; MICE; NEUROPROTECTIVE AGENTS; NITROGEN OXIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 19944365210     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.04.043     Document Type: Article

References (34)

1. B. Halliwell Drugs 42 1991 569
2. C.A. Rice-Evans, and A.T. Diplock Free Rad. Biol. Med. 15 1993 77
3. Myron D. Ginsberg Drug News Perspect. 14 2001 81
4. F. Ringel, and R. Schmid-Elsaesser Expert Opin. Ther. Patents 11 2001 987
5. Ch. Behl, and B. Moosmann Free Rad. Biol. Med. 33 2002 182
6. E.G. Janzen, and B.J. Blackburn J. Am. Chem. Soc. 90 1968 5909
7. E.G. Janzen, and B.J. Blackburn J. Am. Chem. Soc. 91 1969 4481
8. E.G. Janzen Acc. Chem. Res. 4 1971 3
9. K.R. Maples, F. Ma, and Y.-K. Zhang Free Rad. Res. 34 2001 417
10. D.A. Becker, J.J. Ley, L. Echegoyen, and R. Alvarado J. Am. Chem. Soc. 124 2002 4678
11. L.R.C. Barclay, and M.R. Vinqvist Free Rad. Biol. Med. 28 2000 1079
12. S. Lin, Ph.G. Rhodes, M. Lei, F. Zhang, and Z. Cai Brain Res. 1007 2004 132
13. R.A. Floyd FASEB J. 4 1990 2587
14. Q. Zhao, K. Pahlmark, M.L. Smith, and B.K. Siesjö Acta. Physiol. Scand. 152 1994 349
15. K.R. Maples, F. Ma, and Y.-K. Zhang Free Rad. Res. 34 2001 417
16. Z. Zhao, M. Cheng, K.M. Maples, J.Y. Ma, and A.M. Buchan Brain Res. 909 2001 46
17. A.R. Green, T. Ashwood, T. Odergren, and D.M. Jackson Pharm. Ther. 100 2003 195
18. J.W.B. Marshall, A.R. Green, and R.M. Ridley Brain Res. 972 2003 119
19. K. Vukics, G. Tárkányi, F. Dravecz, and J. Fischer Synth. Commun. 33 2003 3419
20. Vukics, K.; Balogh, Gy. T.; Gere, A.; Stadler, K.; Tárká nyi, G.; Fischer, J. Abstracts of Papers, XVIIth International Symposium on Medicinal Chemistry, Barcelona, Spain, 1-5 September 2002; p 531
21. 3: 303.1834. Found: 303.1841
22. B. Taldolini, and L. Cabrini Mol. Cell. Biochem. 94 1990 97 104
23. . scavenging assays were carried out with our modified procedure of Refs. 7,9,11. The modified methods were described in Gy.T. Balogh, J. Illés, Zs. Székely, E. Forrai, and A. Gere Arch. Biochem. Biophys. 410 2003 76
24. M.N. Hughes, and H.G. Nicklin J. Chem. Soc. A 1968 450 452
25. V.B. Bhat, and K.M. Madyastha Biochem. Biophys. Res. Commun. 285 2001 262
26. NO was generated by thermal decomposition of cupferron at 40°C. Increasing concentrations (0.3-100 mM) of samples in 0.5 mL ethanol were mixed with Griess-Ilosvay reagent consisting of 0.5 mL of 0.2% N-(1-naphthyl) ethylenediamine in 0.4 M HCl and 0.5 mL of 2% sulfanilamide in 4 M HCl and 0.5 mL of 0.2% cupferron in ethanol. After 30 min of incubation at 40°C, while the NO formation reached its maximum, the absorption was measured at 540 nm
27. G. Bartosz, A. Janaszewska, D. Ertel, and M. Bartosz Biochem. Mol. Biol. Int. 46 1998 519
28. M. Takei, M. Hiramatsu, and A. Mori Neurochem. Res. 19 1991 1199
29. H. Hara, K. Kogure, H. Kato, A. Ozaki, and T. Sukamoto Eur. J. Pharmacol. 197 1991 75
30. G. Barta-Szalai, A. Gere, K. Takács-Novák, and Gy. Domány Arzneim.-Forsch. 53 2003 722
31. 4 solution and the mixture was incubated for 60 min at 37°C. The reaction was terminated with 20% trichloroacetic acid solution, and the samples were centrifuged. The supernatant was boiled with 0.5% thiobarbituric acid solution for 20 min. Optical density was determined at 532 nm. The inhibitory effect of the test compounds was expressed as the inhibition of TBARs formation
32. C. Backhauss, Ch. Karkoutly, M. Welsch, and J. Krieglstein J. Pharm. Methods 27 1992 27
33. W.C.M. Cramer, and G.P. Toorop Gen. Pharm. 30 1998 195
34. MCA occlusion was performed by electrical coagulation on the right MCA of male NMRI mice. Test compounds were administered i.p. at a dose of 10 mg/kg 30 min after occlusion. Animals were maintained for 48 h under normal conditions, and then their brains were perfused transcardially with an injection of 2,3,5-triphenyltetrazolium chloride (TTC). Animals were decapitated and the infarct area of the brain surface was determined planimetrically by means of an image analyzer system (Digicell 5.0 ASK)